Trading on the TSX will commence March 26, 2018
VANCOUVER, March 23, 2018 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (CSE:IN; OTCQB:IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies,…
